EcoDrugPlus

Sodium Channel Protein Type 4 Subunit Alpha B-Like

Ensembl ID : ENSFHEG00000018490
Gene Symbol: LOC105930265
3 Cross references
245 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSFHEG00000008874
Gene Symbol: SCN4A
3 Cross references
187 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSFHEG00000004206
Gene Symbol: SCN8A
4 Cross references
218 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSFHEG00000021302
Gene Symbol: SCN8A
3 Cross references
219 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSFHEG00000003089
Gene Symbol: LOC105932298
3 Cross references
204 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSFHEG00000022416
Gene Symbol: LOC105935807
3 Cross references
232 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSFHEG00000022368
Gene Symbol: LOC105935844
3 Cross references
241 Possible Orthologues:

Sodium/glucose Cotransporter 2

Ensembl ID : ENSFHEG00000000437
Gene Symbol: LOC105933216
3 Cross references
199 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSFHEG00000016972
Gene Symbol: LOC110366377
2 Cross references
270 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2-Like

Ensembl ID : ENSFHEG00000000130
Gene Symbol: LOC105937883
3 Cross references
205 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233

Ensembl ID : ENSFHEG00000013703
Gene Symbol: LOC105920494
3 Cross references
215 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSFHEG00000017290
Gene Symbol: LOC105925240
3 Cross references
229 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).